Voyager Therapeutics's total assets for Q3 2025 were $288.31M, a decrease of -10.49% from the previous quarter. VYGR total liabilities were $68.49M for the fiscal quarter, a -12.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.